Skip to main content
OpenTrials
Completed

NCT Number: NCT01055587

Diagnostic of Infections Following Major Abdominal Surgery and Burn Injury

This study was designed to investigate, if new biomarkers may improve the early diagnostic of infections following major abdominal surgery and severe burn injuries.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum St. Georg gGmbH

Leipzig, Saxony, 04129, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with major abdominal surgery (e.g. gastrectomy, hemi-/colectomy, resection of sigma or rectum, resection of liver, esophagectomy)
  • patients following severe burn injury (burn surface area >= 15%)
  • age >= 18 years
  • informed consent

Exclusion criteria

  • no informed consent
  • emergency surgery
  • immunocompromising diseases (e.g. HIV+, AIDS, Lymphoma or NonHodgkin-Lymphoma, Autoimmune-Diseases)
  • pre-existing liver or renal failure
  • chronic therapy with corticoids

Treatment and study plan

Primary outcomes

  1. rate of infections

    Time frame: day 28 post intervention

Sponsors and collaborators

Lead sponsor

Klinikum St. Georg gGmbH

Other

Collaborators

  • Martin-Luther-Universität Halle-Wittenberg

Registry information

Official study title

Impact of Biomarkers for Early Diagnostic of Infections Following Major Abdominal Surgery and Severe Burn Injuries

Acronym: Earlygnost

Important dates

Study start
2009
Primary completion
2015
Study completion
2015
First posted
Jan 25, 2010
Registry last updated
Feb 8, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.